0001387131-11-002069.txt : 20110915 0001387131-11-002069.hdr.sgml : 20110915 20110915095822 ACCESSION NUMBER: 0001387131-11-002069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110913 FILED AS OF DATE: 20110915 DATE AS OF CHANGE: 20110915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nova Tina Susan CENTRAL INDEX KEY: 0001302605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26372 FILM NUMBER: 111092138 MAIL ADDRESS: STREET 1: C/O ARENA PHARMACEUTICALS, INC. STREET 2: 6166 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER NAME: FORMER CONFORMED NAME: Nova Bennett Tina DATE OF NAME CHANGE: 20080226 FORMER NAME: FORMER CONFORMED NAME: Nova Tina Susan DATE OF NAME CHANGE: 20040908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 4 1 q11-00712.xml X0304 4 2011-09-13 0 0000887247 Adamis Pharmaceuticals Corp ADMP 0001302605 Nova Tina Susan C/O ADAMIS PHARMACEUTICALS CORPORATION 11455 EL CAMINO ROAD. SUITE 310 DEL MAR CA 92014 1 0 0 0 Employee Stock Option (right to buy) 0.18 2011-09-13 4 A 0 35000 0 A 2021-09-13 Common Stock 35000 35000 D The option shall vest and become exercisable as to 1/36th of the total shares subject to the option on each monthly anniversary of the grant date, such that the option is fully vested and exercisable on the third anniversary of the grant date, so long as the optionee continuously remains a director or employee of, or consultant to, the Company. /s/Robert O. Hopkins, Power of Attorney for Tina S. Nova, Ph.D. 2011-09-14